Leading brokers name 3 ASX shares to sell today

Here's why brokers are bearish on these ASX shares…

| More on:
Business man marking Sell on board and underlining it

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday I looked at three ASX shares brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here's why these brokers are bearish on these ASX shares:

Flight Centre Travel Group Ltd (ASX: FLT)

According to a note out of Citi, its analysts have retained their sell rating but lifted their price target on this travel agent's shares to $18.31. The broker believes there are risks to near-term earnings that are not being factored in by investors. In addition, over the medium term Citi expects the shift online to slow its growth. So with Flight Centre's shares trading at 17x estimated FY 2024 earnings, the broker believes they have run ahead of fundamentals and are overvalued. The Flight Centre share price is trading at $21.28 on Tuesday afternoon.

Pro Medicus Limited (ASX: PME)

Another note out of Citi reveals that its analysts have initiated coverage on this health imaging technology company's shares with a sell rating and $45.00 price target. Citi believes that investors are being too optimistic on the company's future growth. Especially given the potential release of competing products down the line, which could squeeze the company's very generous 60%+ profit margins. The Pro Medicus share price is fetching $58.86 today.

REA Group Limited (ASX: REA)

Analysts at UBS have downgraded this property listings company's shares to a sell rating but increased their price target on them to $170.00. While the broker acknowledges that REA delivered a very strong first quarter result and has upgraded its earnings estimates to reflect this, it can't ignore its valuation. The broker believes REA's shares are expensive at the current level. Particularly given likely listings volatility and the potential for headwinds from Australia's next federal election and possible regulatory intervention. The REA share price is trading at $170.29 on Tuesday.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Flight Centre Travel Group Limited and REA Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker tips 50%+ upside for IDP Education shares

The team at Macquarie thinks this beaten down stock could be a buy.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in June

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Bell Potter says this ASX 200 share can rise 25%

Let's see what the broker is saying about this stock.

Read more »

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

9 ASX 200 shares just upgraded to strong buy ratings

Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Brokers say pull the plug on these 3 ASX 200 shares

Experts say it's time to press the sell button on these ASX 200 shares. Find out why.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Macquarie forecasts 40% upside for this ASX All Ords stock

Let's see which stock the broker is tipping as a buy.

Read more »